[Springer] Unveiling the Safety Landscape of Tremelimumab Plus Durvalumab (STRIDE Regimen) Immunotherapy in Unresectable Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

Serene_tran Post time The day before yesterday 23:17 | Show all posts |Read mode
This post will be closed automatically in 2026-09-16 23:09
Reward10points

Journal: Journal of Pharmaceutical Innovation
Authors: Helal F. Hetta, Fawaz E. Alanazi, Mashan L. Abdullah, Ali S. Alfardan, Mohammed A. Al-Hamamah, Fahad Abdullah Alshahrani, Fahad O. Alatawi, Salwa Qasim Bukhari, Zinab Alatawi, Kamel A. Saleh & Reem Sayad
Published date: 08 September 2026
DOI: https://doi.org/10.1007/s12247-026-11014-x
Article link: https://doi.org/10.1007/s12247-026-11014-x
Article source: Springer Nature Link








Reply

Use magic Donate Report

All Reply1 Show all posts
radeonbb Post time The day before yesterday 23:34 | Show all posts

Waiting for confirmation

If the PDF has not been accepted after 72 hours, the system will automatically adopt it.
Reply

Use magic Donate Report

Return to the list